Unlock instant, AI-driven research and patent intelligence for your innovation.

The pharmaceutical small molecule compound of the vsig8 small molecule inhibitor and its medical use and pharmaceutical composition

A technology of small molecule inhibitors and compounds, applied in the field of biomedicine, can solve the problems of high price, complex preparation process of antibody drugs, inconvenient use, etc., and achieve the effect of promoting value-added

Active Publication Date: 2021-06-01
CHINA PHARM UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, antibody drugs have the disadvantages of complex preparation process, high price, and inconvenient use, and the clinical trial of VISTA oral drug CA-170 as a dual inhibitor of VISTA and PD-L1 for the treatment of solid tumors has also entered into clinical research (NCT02812875), which proves that Potential value of VISTA as a new target in drug development
[0003] To date, there are no literature reports involving small molecule inhibitors of VSIG8

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • The pharmaceutical small molecule compound of the vsig8 small molecule inhibitor and its medical use and pharmaceutical composition
  • The pharmaceutical small molecule compound of the vsig8 small molecule inhibitor and its medical use and pharmaceutical composition
  • The pharmaceutical small molecule compound of the vsig8 small molecule inhibitor and its medical use and pharmaceutical composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Expression and preparation of human extracellular segment VSIG8-His fusion protein

[0041] Rabbit anti-human VSIG8 antibody (ab83852) was purchased from Abcam; rabbit secondary antibody (CW0156) was purchased from Biyuntian Biotechnology Co., Ltd.;

[0042] 1. Recovery culture of ExpiCHO-STM cells

[0043] Take the frozen ExpiCHO-STM cells out of liquid nitrogen, thaw them in a water bath at 38-39°C, and keep shaking them to make them melt quickly until only a small amount of ice cubes remain in the tube. Remove the cells from the water bath Take it out from the tube, spray it with 75% alcohol and open it in an ultra-clean bench, transfer the cell suspension (1mL) in the cryopreservation tube to a cell shaker flask containing 29mL Expi CHO expression medium (Gibco, A2910001) prepared in advance , place the cell shaker flask at 37°C, CO 2 The concentration is 8%, cultured in an incubator with a shaker rotation speed of 130 rpm.

[0044] Three days after recovery, whe...

Embodiment 2

[0077] Screening of Affinity Molecules of VSIG8 Protein by Competitive ELISA

[0078] Competitive ELISA method is used to screen the affinity molecules of VSIG8 protein, and the affinity of the screened objects to VSIG8 protein can be characterized through simple co-incubation, washing and color development steps. Mainly rely on the reaction of horseradish peroxidase and TMB chromogenic solution to produce a color change for detection. During the experiment, the VSIG8 protein was coated on the ELISA plate by physical adsorption, and the non-specific binding sites that were not saturated by the protein at the bottom of the plate were removed after washing and blocking steps, and then the test object and VSIG8-specific antibody mixture were added. Finally, secondary antibody and TMB were added for color development, and the absorbance at 450 nm was detected. If the detection object does not bind to the VSIG8 protein, the detection antibody will completely react with VSIG8, and th...

Embodiment 3

[0088] Microscale Thermophoresis (MST) assay was used to screen and identify the affinity molecules of VSIG8 protein. The ELISA method in Example 2 can characterize the affinity of the screening object for the VSIG8 protein through simple co-incubation, washing and color development steps. Molecules with better activity after screening by ELISA experiments will continue to be verified by MST experiments in the later stage to verify the affinity of the molecules with VSIG8 protein. The MST experiment refers to the directional movement of molecules in the microscopic temperature gradient field. Through the infrared excitation in the center of the capillary pipette and the cooling of the periphery, the temperature gradient difference in the microscopic area is generated in the capillary pipette, and the protein to be measured is compared with the small one. The molecular mixture solution is filled into the capillary pipette, and then the strength of the binding ability of the pro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses a small-molecule pharmaceutical compound of a VSIG8 small-molecule inhibitor, its medical application and a pharmaceutical composition, such as the application of the compound L557‑0155 or its pharmaceutically acceptable salt or solvate in the preparation of a VSIG8 inhibitor; The structure of compound L557‑0155 is as follows: the present invention provides a small molecule inhibitor of VSIG8 for the first time, and the present invention finds for the first time that compound L557‑0155 can significantly bind to VSIG8 protein through molecular and cellular experiments, thereby promoting IFN‑γ, TNF‑α The release of cytokines such as VSIG8 can be used as a small molecule inhibitor of VSIG8 for the treatment of tumor diseases.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and in particular relates to a small-molecule compound of a VSIG8 small-molecule inhibitor, as well as its medical use and pharmaceutical composition. Background technique [0002] V-domain immunoglobulin suppressor of T-cell activation (VISTA) is a negative immune checkpoint that can inhibit the immune response of T cells, and its natural binding receptor is VSIG8 (V- Set and Immunoglobulin domain containing 8, VSIG8). VISTA is a type I transmembrane protein, mainly expressed in hematopoietic cells, granulocytes and T cells. VSIG8 is predominantly in the spleen, CD3 + , CD4 + , CD8 + Expressed in T cells, and human and mouse VSIG8 have 86% homology. Flow cytometry results showed that VISTA protein can specifically bind to VSIG8 protein, and human VISTA protein can bind to mouse VSIG8 protein. Studies have found that the combination of VISTA and VSIG8 can inhibit the activity of DO11.10...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/4439A61P35/00A61P35/02C07D401/04
CPCA61K31/4439A61P35/00A61P35/02C07D401/04
Inventor 柳军孙宏斌王岚岚张陆勇江经纬
Owner CHINA PHARM UNIV